12/13 DVT - Corbett Flashcards
normal venous anatomy
three systems
veins as low pressure system
three systems need to be intact for normal venous flow from lower limb
- veins superficial to deep muscle fascia (saphenous veins)
- deep veins (intramuscular, intermuscular vv that run with aa)
- perforating vv
veins are generally a low pressure system BUT weight of columns of blood can creat pressure due to gravity (up to 90mm in standing adult)
how do veins mitigate pressure?
venous valves and venous pump
-
valves: bicuspid valves arranged to ensure blood flow towards heart/prevent backflow (more distal)
* also prevents blood in deep system from moving over to superficial system - venous pump: contraction of LE muscle “pumps” blood
- contingent on competent valves
- reduces walking venous pressure to 20mm!
why does standing still for long time lead to edema?
standing still for prolonged periods → incr cap pressure → fluid lead/volume loss
- 10-20% of blood vol can be lost within 15-30min!!!
how do thrombi form in venous system?
how do thrombi form in arterial system?
arterial system
- HIGH shear stress
- endothelial cells disrupted
- platelet-rich (therefore…drug tx is anti-platelet)
- “white clots”
venous system
- LOW shear stress
- endothelial cells intact
- fibrin-rich (therefore…drug tx is anti-coagulant)
- “red clots”
pathogenesis of DVT
triad and factors that affect them
VIRCHOW’S TRIAD
- hypercoagulable state
- genetic factors
- acquired risks
- endothelial injury
* EC activation somehow (without being stripped or denuded…not clear what is activating them to make them less anti-thrombogenic) - stasis
- disruption of flow is worst with immobilization
- valve sinuses are the site of thrombus initiation
- could be that stasis of blood in those pockets causes hypoxia → EC activation!
role of TF in DVT
Tissue Factor is a transmembrane protein which is not usually accessible
- synthesized and expressed by endothelial cells and monocytes
- once expressed, triggers first step in extrinsic coag pathway
risk for DVT
- endothelial damage
- endothelial dysfx
- smoking
- HTN
- endothelial damage
- surgery
- catheter
- trauma
- hypercoagulability
- hereditary
- Factor V Leiden
- Prothrombin G20210A
- Protein C and S deficiency
- acquired
- cancer
- chemotx
- pregnancy
- obesity
- HIT
- stasis
- immobility
- polycythemia
heriditary risk factors for DVT
all autosomal dominant
- Factor V Leiden mutation
- Prothrombin gene mutation
- Protein C deficiency
- anti-thrombin deficiency
- Protein S deficiency
review of coag cascade @17min-21min
Factor V Leiden mutation
most common inherited thrombophilic disorder
- point mutation changing Arg → Gln at position 506
Factor V is resistant to activated Protein C (APC; anticoag!!!)
_end resul_t: Factor V stays around, continues to interact with Factor X and boost coagulation
relative risk_Factor V Leiden = 5
relative risk_OCP = 4
relative risk_both = 30
prothrombin mutation
second most common inherited thrombophilic disorder
- mutation in 3’ UTR of prothrombin gene
- glycine → alanine: 20210
- leads to 30% increase in circulating prothrombin via unclear mech
protein C deficiency
nonsense mutation → decr quantity of Protein C
clinical conditions:
- VTE at multiple venous sites
- Warfarin-induced skin necrosis
- neonatal purpura fulminans
- homozygous def
anti-thrombin deficiency
decr AT3 caused by:
- AT3 deficiency (insertion or deletion)
- functional deficiency
clinical conditions:
- incr thrombotic risk (esp in pregnancy)
- insensitivity to heparin
when should a patient with DVT be evaluated for a hypercoagulable disorder?
routine testing for unselected pts NOT recommended
consider if:
- one first deg relative with DVT < 45
- young pt (< 45) with first DVT
- thrombosis in unusual vascular beds
- hepatic, portal, mesenteric, cerebral
- warfarin induced-skin necrosis
- arterial thrombosis
acquired risk factors
MOIST
M: malignancy, motherhood, myeloproliferative disorders
O: oral contraceptives, obesity, orthopedics
I: immobilization, infl bowel disease, indwelling central line
S: surgery, syndromes (anti-phospholipid antibody and nephrotic syndrome)
T: trauma, tamoxifen, prior thrombosis